a 2017

Immunomonitoring of patients treated with personalized dendritic cell-based vaccine

FĚDOROVÁ, Lenka, Lenka ZDRAŽILOVÁ DUBSKÁ, Kateřina PILÁTOVÁ, Peter MÚDRY, Pavel MAZÁNEK et. al.

Basic information

Original name

Immunomonitoring of patients treated with personalized dendritic cell-based vaccine

Authors

FĚDOROVÁ, Lenka (203 Czech Republic), Lenka ZDRAŽILOVÁ DUBSKÁ (203 Czech Republic, belonging to the institution), Kateřina PILÁTOVÁ (203 Czech Republic), Peter MÚDRY (203 Czech Republic, belonging to the institution), Pavel MAZÁNEK (203 Czech Republic, belonging to the institution), Zdeněk PAVELKA (203 Czech Republic, belonging to the institution), Eva HLAVÁČKOVÁ (203 Czech Republic, belonging to the institution), Jaroslav ŠTĚRBA (203 Czech Republic, belonging to the institution), Lucie FLAJŠAROVÁ (203 Czech Republic, belonging to the institution), Regina DEMLOVÁ (203 Czech Republic, belonging to the institution) and Dalibor VALÍK (203 Czech Republic)

Edition

2017

Other information

Language

English

Type of outcome

Konferenční abstrakt

Field of Study

30200 3.2 Clinical medicine

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 13.930

RIV identification code

RIV/00216224:14110/17:00098841

Organization unit

Faculty of Medicine

ISSN

Keywords in English

cell-based vaccine

Tags

Změněno: 16/12/2017 15:41, Soňa Böhmová

Abstract

V originále

Abstract Immunomonitoring of patients treated with personalized dendritic cell-based vaccine.

Links

LM2015090, research and development project
Name: Český národní uzel Evropské sítě infrastruktur klinického výzkumu (Acronym: CZECRIN)
Investor: Ministry of Education, Youth and Sports of the CR